Table 3 Relationship between clinical pathological features and ERα expression in HCC (TCGA)
Characteristics | Low ESR1 | High ESR1 | χ2 | p value |
|---|---|---|---|---|
n | 187 | 187 | ||
Gender, n (%) | 5.387711103 | 0.02* | ||
Male | 116 (45.8%) | 137 (54.2%) | ||
Female | 71 (58.7%) | 50 (41.3%) | ||
Age, n (%) | 8.116021437 | 0.004* | ||
<= 60 | 102 (57.6%) | 75 (42.4%) | ||
> 60 | 84 (42.9%) | 112 (57.1%) | ||
Pathologic T stage, n (%) | 7.264436529 | 0.026* | ||
T1 | 80 (43.7%) | 103 (56.3%) | ||
T2 | 51 (53.7%) | 44 (46.3%) | ||
T3&T4 | 56 (60.2%) | 37 (39.8%) | ||
Pathologic N stage, n (%) | 1.930530942 | 0.165 | ||
N0 | 133 (52.4%) | 121 (47.6%) | ||
N1 | 4 (100%) | 0 (0%) | ||
Pathologic M stage, n (%) | 1.791825528 | 0.181 | ||
M0 | 144 (53.7%) | 124 (46.3%) | ||
M1 | 4 (100%) | 0 (0%) |